Search Results for 'Clinical Trial'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | Information Technology
Ashfield Engage, Popit Form Digital Monitoring Collaboration
Partner to improve patient adherence through supplemental real-time personalized support.Tim Wright, Editor, Contract Pharma 02.26.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement
Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.Kristin Brooks 02.22.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
RedHill and Cosmo Strengthen Manufacturing Agreements
Secures manufacturing capacity of Movantik for opioid-induced constipation and RHB-204, currently in a Phase 3 study for pulmonary NTM disease.Tim Wright, Editor, Contract Pharma 02.19.21
-
Breaking News | Clinical Trials | CRO News
PPD Awarded US Army RPA Develop PTSD Drugs
Adaptive platform clinical research trial design aims to expedite potential new treatments for veterans.Kristin Brooks 02.18.21
-
APIs | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cascade Chemistry Begins $14M cGMP Mfg. Capacity Expansion
Will triple floor space and increase manufacturing capacity for APIs for clinical trial materials and ultimately commercial production.Kristin Brooks 02.18.21
-
Clinical Trial Start-Up: Effective Planning for Sponsors, CROs, and Sponsor-Investigators
...02.17.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
For EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody.Tim Wright, Editor, Contract Pharma 02.12.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Recipharm Bolsters Biologics Offering
Extends manufacturing license to include immunology products at clinical and commercial scales, in both freeze-dried and liquid forms.Kristin Brooks 02.11.21
-
Clinical Trials | Information Technology
Top 5 Things to Know Before Selecting Clinical Trial Technology
Look for a future-proof model, innovative vendors - not cutting-edge technology, and focus on user-centered design and interoperability.Andres Garcia, Co-founder and CTO Florence 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China
Companies join forces in cell therapy applications and commercial-scale manufacturing.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Trizell Enter Cell Therapy Deal
Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.Tim Wright, Editor, Contract Pharma 02.08.21
-
Biologics, Proteins, Vaccines | Clinical Trials
Inside a Vaccine Trial
Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.Online Exclusives Kristin Brooks, Managing Editor 02.05.21
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
CDMO Famar and Active Biotech Ink Clinical Manufacturing Deal
Will deliver clinical trial material of the newly developed eye-drop formulation of laquinimod.Tim Wright, Editor, Contract Pharma 02.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Catalent, Decibel Team Up for Hearing Loss Treatment
Enter development and manufacturing agreement for dual-vector gene therapy for the treatment of congenital hearing loss.Tim Wright, Editor, Contract Pharma 02.04.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
Affimed, Roche Explore AFM24, Tecentriq Combo
To investigate the combination for the treatment of advanced solid epidermal growth factor receptor (EGFR) expressing malignancies.Kristin Brooks 02.03.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement
Abzena will work with Immunome to produce the antibody cocktail for clinical testing.Kristin Brooks 02.03.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trials | Collaborations & Alliances | Industry News
RedHill and Cosmo Expand Opaganib Manufacturing Deal
New agreement expands manufacturing capacity for orally-administered opaganib following positive top-line data from its Phase 2 COVID-19 study.Tim Wright, Editor, Contract Pharma 02.02.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
DoD Awards Rigel $16.5M to Support Fostamatinib COVID Trials
Will evaluate the safety and efficacy of fostamatinib in hospitalized COVID-19 patients without respiratory failure.Kristin Brooks 02.01.21
-
Clinical Trials | Information Technology
The State of Clinical Trial Technology
Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.Online Exclusives Kristin Brooks, Contract Pharma 01.26.21
-
Clinical Trials
The Future of Clinical Trials Series: Part II
Greater awareness will ensure diversity is no longer an afterthought and patients will be at the center of every aspect of clinical research.Jena Daniels, Rasmus Hogreffe, Ingrid Oakley-Girvan, Dr. Michelle Longmire, Medable 01.26.21
-
Breaking News | Clinical Trials | Industry News
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.Kristin Brooks 01.26.21
-
Breaking News | Clinical Trials | Drug Development | Industry News | Laboratory Testing
Caprion-HistoGeneX Rebrands as CellCarta
Recently expanded its scientific capabilities and geographic presence with the acquisitions of Clinical Logistics Inc. and Mosaic Laboratories.Kristin Brooks 01.26.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Humanigen, Emergent Enter Covid-19 Partnership
Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.Tim Wright, Editor, Contract Pharma 01.25.21
-
Aseptic Processing | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Fill/Finish | Industry News
Piramal Inks Clinical Supply Deal with Theratechnologies
CDMO to provide sterile fill/finish drug product formulation and manufacturing from its Lexington, KY facility.Tim Wright, Editor, Contract Pharma 01.21.21
-
Clinical Trials
The Future of Clinical Trials Series: Part I
What will 2021 have in store for an industry in flux?Alison Holland, Head of Decentralized Trials, Medable, Maria Fotiu, Executive Vice President of Decentralized Solutions, Syneos Health 01.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Intravacc Completes Project for Provention Bio’s Vax Candidate
Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.Contract Pharma Staff 01.19.21
-
Breaking News | Clinical Trials | Industry News
Grifols Begins COVID-19 Plasma Treatment Trial
Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.Contract Pharma Staff 01.18.21
-
Clinical Trials | Drug Development | Information Technology
Virtual Clinical Trials: The Future of Dermatology Studies
COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21
-
Breaking News | Clinical Trials | CRO News | Industry News
Frontage Bolsters Clinical Services Capabilities
Unveils plans to provide full service human radiolabeled absorption, metabolism, and excretion study capabilities.Contract Pharma Staff 01.15.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Breaking News | Clinical Trials | CRO News
Parexel Completes Strategic Separation
Aims to simplify and streamline business strategy and customer relationships while positioning both organizations for long-term growth.Contract Pharma Staff 01.12.21
-
Clinical Trials | CRO News
Caprion-HistoGeneX Acquires Clinical Logistics
Expands its support of clinical trials specimen logistics.Contract Pharma Staff 01.08.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Breaking News | Clinical Trials | Promotions & Moves
Parexel Appoints Chief Patient Officer
Demonstrates the company’s commitment to elevating the patient perspective.Contract Pharma Staff 01.06.21
-
Breaking News | Clinical Trials | CRO News
Genesis Biotechnology Acquires STATKING Clinical Services
Expands its presence in the clinical space.Contract Pharma Staff 01.06.21
-
Clinical Trials
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Will manufacture second-generation COVID-19 vaccine, AKS-452.Contract Pharma Staff 01.05.21
-
Clinical Trials | Drug Development
Impact of Decentralized Trials in Oncology Drug Development
Join us on 2/9 as clinical, regulatory and real-world evidence experts discuss the impact of decentralized trials on the evolution of drug dev in oncology.01.04.21
-
Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Lonza Expands Conjugation Facility in Visp
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.Contract Pharma Staff 12.21.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.Contract Pharma Staff 12.17.20
-
Breaking News | Clinical Trials | CRO News | Drug Development
Ergomed Acquires MedSource
Specialist oncology and rare disease CRO further expands Ergomed’s presence in the U.S. market.Contract Pharma Staff 12.15.20
-
Clinical Trials | Drug Development | Information Technology
Advancing Digital Endpoints in Clinical Trials
An end-to-end approach to managing wearable devices through clinical development.Online Exclusives Kristin Brooks, Contract Pharma 12.14.20
-
Clinical Trials | Information Technology
Life Sciences Strive for Greater Agility
Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.Ronan Brown, SVP of Integrated Technology & Compliance, and Joe Rymsza, VP, Global PV & Regulatory Technology Solutions, IQVIA 12.14.20
-
Clinical Trials | Drug Development | Information Technology
Advances in Intelligent Automation
The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20
-
APIs | Breaking News | Clinical Trial Materials | Facilities | Industry News
Recipharm Expands API Manufacturing Capabilities
Invests $2.5 million in clinical GMP capacity for APIs at Israel facility.Contract Pharma Staff 12.09.20
-
Clinical Trials
Adapting to Pandemic Restrictions While Launching a Phase 3 Trial
The pandemic has forced companies to reimagine how trials can be conducted, and to think differently about the future of all their clinical trials.
-
Breaking News | Clinical Trials | Industry News
SGS Initiates U.S. COVID-19 Clinical Trials
Phase 2/3 trial will examine the safety, tolerability, and efficacy of Sarconeos (BIO101) to treat COVID-19 related respiratory failure.Contract Pharma Staff 11.30.20
-
Breaking News | Clinical Trials | Industry News
Merck Acquires OncoImmune for $425M
Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19.Contract Pharma Staff 11.24.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
Expect to produce globally up to 50 million doses in 2020, up to 1.3 billion doses by the end of 2021; ready to distribute within hours after authorization.Contract Pharma Staff 11.20.20
